PZ Cormay S.A. (WSE:CRM)

-9.15% (1Y)

Market Cap	43.45M
Revenue (ttm)	92.02M
Net Income (ttm)	-4.41M
Shares Out	84.21M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,450
Average Volume	14,411
Open	0.5140
Previous Close	0.5180
Day's Range	0.4970 - 0.5160
52-Week Range	0.3550 - 0.6180
Beta	0.91
RSI	45.59
Earnings Date	Sep 19, 2025

About PZ Cormay

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents and medical equipment in Poland. The company offers biochemistry, including analyzers, reagents, cleaning liquids, control materials, and calibators. It also offers general analytics, such as test strips, checks, and calibration strips. It offers parasitology, such as MINI-SYSTEM PARAGREEN. In addition, the company offers Immunochemistry, includes SNIBE, MINDRAY, DIESSE, AliveDX. It provides molecular biology, such as RT-PCR systems, Systems for the isolation of genetic materi...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1985
• Employees: 825
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: CRM

Financial Performance

In 2024, PZ Cormay's revenue was 91.62 million, an increase of 11.43% compared to the previous year's 82.23 million. Losses were -5.27 million, 16.2% more than in 2023.